Prevention of Viral Hepatitis and HIV in Drug Users - A Hepatitis B Model for HIV and an HB Vaccine Model for HIV Vaccine Trials in Drug Users (DASH)

Request Access

Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial.

L. Hwang, C. Grimes, T. Q. Tran, et al.. (2010). The Journal of infectious diseases. Cited 58 times. https://doi.org/10.1086/656776

Immune response to hepatitis B vaccination in drug using populations: a systematic review and meta-regression analysis.

Geetanjali R. Kamath, D. Shah, L. Hwang. (2014). Vaccine. Cited 37 times. https://doi.org/10.1016/j.vaccine.2014.02.072

Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.

T. Q. Tran, C. Grimes, D. Lai, et al.. (2012). Vaccine. Cited 22 times. https://doi.org/10.1016/j.vaccine.2011.10.084

Demographics, socio‐behavioral factors, and drug use patterns: What matters in spontaneous HCV clearance?

D. Shah, C. Grimes, E. Brown, et al.. (2012). Journal of Medical Virology. Cited 18 times. https://doi.org/10.1002/jmv.22271

Differentially regulated gene expression associated with hepatitis C virus clearance.

C. Grimes, L. Hwang, P. Wei, et al.. (2013). The Journal of general virology. Cited 10 times. https://doi.org/10.1099/vir.0.047738-0
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747